Accuray Incorporated (ARAY) 5.30 $ARAY
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 102.53 (-1.78), EW: 101.52 (-0.96), ARAY: 5.30 (-0.30), SYK: 114.56 (-0.77)
Accuray to Participate in the 2016 Jefferies Healthcare Conference
PR Newswire - Wed May 25, 6:00AM CDT
Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference in New York, NY on Friday, June 10, 2016 at 8:00 a.m. ET.
ARAY: 5.30 (-0.30)
Accuray to Host Analyst and Investor Day on May 20, 2016
PR Newswire - Thu May 19, 6:00AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst and Investor Day on Friday, May 20, 2016 at the Lotte Palace Hotel in New York City.
ARAY: 5.30 (-0.30)
Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System
PR Newswire - Sun May 01, 10:55PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with medPhoton GmbH to collaborate on integration of its ImagingRing® system, a new technology for volumetric image guidance, with the CyberKnife® System. The ImagingRing provides a range of advanced imaging capabilities including large field-of-view cone beam CT. This long-term strategic agreement will provide Accuray with certain exclusive development, sales and distribution rights of the unique ImagingRing for use in adaptive radiation therapy, SBRT and robotic radiosurgery.
ARAY: 5.30 (-0.30)
Accuray to Unveil Latest Innovations at Estro
PR Newswire Europe - Thu Apr 28, 2:02AM CDT
SUNNYVALE, California, April 28, 2016 /PRNewswire/ --
ARAY: 5.30 (-0.30)
Accuray (ARAY) Posts Earnings in Q3, Down on View Cut
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:55AM CDT
Shares of Accuray Inc. (ARAY) fell 3.3% in after-hours trading following the company's third-quarter fiscal 2016 results and trimmed fiscal 2016 guidance.
INGN: 49.46 (-0.77), EXAC: 25.42 (+0.12), ARAY: 5.30 (-0.30), HOLX: 34.14 (-0.81)
Accuray beats 3Q profit forecasts
Automated Insights - Tue Apr 26, 4:05PM CDT
SUNNYVALE, Calif. (AP) _ Accuray Inc. (ARAY) on Tuesday reported fiscal third-quarter net income of $756,000, after reporting a loss in the same period a year earlier.
ARAY: 5.30 (-0.30)
Accuray Submits 510(k) Premarket Notification to FDA for Its Radixact(TM) Treatment Delivery System
PR Newswire - Tue Apr 26, 3:05PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today the submission of its 510(k) premarket notification with the Food and Drug Administration (FDA) for the company's Radixact(TM) Treatment Delivery System. Accuray also submitted 510(k) premarket notification for its treatment planning and data management systems, Precision(TM) Treatment Planning System and iDMS(TM) Data Management System.
ARAY: 5.30 (-0.30)
Accuray Generates $105.3 Million in Third Quarter Revenues
PR Newswire - Tue Apr 26, 3:01PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2016.
ARAY: 5.30 (-0.30)
Accuray Hosts Regional AERO Users' Meeting
PR Newswire - Fri Apr 22, 5:00AM CDT
Accuray Incorporated (Nasdaq: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO(TM)) Users' Meeting was held April 10 - 11, 2016 at the Palace Hotel in San Francisco, California. The two day summit, coordinated in partnership with teams from several University of California campuses, brought together radiation oncologists, physicists, therapists and administrators from around the world to discuss best practices and the future of radiation oncology. Founded in 2011, AERO was created for CyberKnife® System and TomoTherapy® System users dedicated to advancing patient care through worldwide clinical and technical collaboration.
ARAY: 5.30 (-0.30)
Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 36.39 (-0.32), GMED: 24.63 (-0.54), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)
T2 Biosystems (TTOO) Rises: Stock Adds 7.6% in Session
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 7:45AM CDT
T2 Biosystems, Inc. (TTOO) was a big mover last session, as the company saw its shares rise over 7% on the day.
TTOO: 8.90 (-0.26), ARAY: 5.30 (-0.30)
Accuray To Report Results For Third Quarter Fiscal 2016 On April 26, 2016
PR Newswire - Wed Apr 06, 1:14PM CDT
Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2016 on April 26, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.
ARAY: 5.30 (-0.30)
Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 24.63 (-0.54), MZOR: 15.78 (-0.18), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)
TransEnterix (TRXC) in Focus: Stock Surges 10% in Session
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 7:35AM CDT
TransEnterix, Inc. (TRXC) was a big mover last session, as the company saw its shares surge 10% on the day.
TRXC: 1.45 (+0.01), ARAY: 5.30 (-0.30)
TransEnterix in Focus: Stock Surges 10% in Session
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 7:35AM CDT
TransEnterix, Inc. (TRXC) was a big mover last session, as the company saw its shares surge 10% on the day.
TRXC: 1.45 (+0.01), ARAY: 5.30 (-0.30)
MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients with the CyberKnife® System
PR Newswire - Thu Mar 31, 5:00AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that MedStar Georgetown University Hospital in Washington, D.C. treated its 1,000th prostate cancer patient with the leading-edge CyberKnife® System. The System was designed to deliver stereotactic body radiation therapy (SBRT), a treatment process necessitating an extremely high degree of precision. SBRT is a much shorter course of treatment for prostate cancer patients than conventional radiation and is noninvasive (no surgery involved).
ARAY: 5.30 (-0.30)
Meet the Biotech Company About to Turn the 120-Year-Old Cancer Radiation Industry on Its Head
ACCESSWIRE - Fri Mar 18, 1:49PM CDT
WINDSOR, ON / ACCESSWIRE / March 18, 2016 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to highlight a new stock pick, Advanced Medical Isotope (OTC: ADMD), which WBT believes has the ability to cause a massive paradigm shift in the cancer treatment space, and potentially capture a large segment of the burgeoning internal radiation therapy market. We look to follow this company as they expect to make another FDA submission later this year, which should catapult the stock if they receive the anticipated marketing clearance. We also contrast and compare a few other companies in the industry.
ATNM: 1.82 (unch), ISR: 0.81 (+0.01), ARAY: 5.30 (-0.30)
Better Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated
Brian Stoffel, The Motley Fool - Motley Fool - Wed Feb 10, 4:01PM CST
Source: Public domain, Pixabay The Nasdaq Composite has had a downright awful seven-week stretch. Since peaking in late December, the collection of companies has seen its value drop by almost 16%. Two of the leading medical tech companies...
ISRG: 641.59 (-6.61), ARAY: 5.30 (-0.30)
Accuray (ARAY) Q2 Loss Wider than Estimate, Shares Fall
Zacks Equity Research - Zacks Investment Research - Mon Feb 01, 9:43AM CST
Shares of Accuray Inc. (ARAY) plunged 8.1% to close at $5.33 on Jan 29 following its dismal second quarter fiscal 2016 earnings results.
GILD: 84.45 (-1.32), EXAC: 25.42 (+0.12), INFI: 4.81 (-0.23), ARAY: 5.30 (-0.30)
How Rewarding Investors Believe These Medical Appliances and Equipment Stocks are? - Edwards Lifesciences, Stryker, Accuray, and ABIOMED
PR Newswire - Wed Jun 08, 7:55AM CDT
Increasing demands for new developments are driving up growth in the Medical Appliances and Equipment space, one of the biggest industries in the U.S. Healthcare sector. ActiveWallSt.com has lined the following stocks for investors' assessment: Edwards Lifesciences Corp. (NYSE: EW), Stryker Corp. (NYSE: SYK), Accuray Inc. (NASDAQ: ARAY), and ABIOMED Inc. (NASDAQ: ABMD). Access these stocks complimentary alerts at:
ABMD: 102.53 (-1.78), EW: 101.52 (-0.96), ARAY: 5.30 (-0.30), SYK: 114.56 (-0.77)
Accuray to Participate in the 2016 Jefferies Healthcare Conference
PR Newswire - Wed May 25, 6:00AM CDT
Accuray Incorporated (NASDAQ: ARAY), announced today that Joshua H. Levine, President and Chief Executive Officer, is scheduled to present at the Jefferies Healthcare Conference in New York, NY on Friday, June 10, 2016 at 8:00 a.m. ET.
ARAY: 5.30 (-0.30)
Accuray to Host Analyst and Investor Day on May 20, 2016
PR Newswire - Thu May 19, 6:00AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that the Company will host an Analyst and Investor Day on Friday, May 20, 2016 at the Lotte Palace Hotel in New York City.
ARAY: 5.30 (-0.30)
Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife® System
PR Newswire - Sun May 01, 10:55PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that the company has signed an agreement with medPhoton GmbH to collaborate on integration of its ImagingRing® system, a new technology for volumetric image guidance, with the CyberKnife® System. The ImagingRing provides a range of advanced imaging capabilities including large field-of-view cone beam CT. This long-term strategic agreement will provide Accuray with certain exclusive development, sales and distribution rights of the unique ImagingRing for use in adaptive radiation therapy, SBRT and robotic radiosurgery.
ARAY: 5.30 (-0.30)
Accuray to Unveil Latest Innovations at Estro
PR Newswire Europe - Thu Apr 28, 2:02AM CDT
SUNNYVALE, California, April 28, 2016 /PRNewswire/ --
ARAY: 5.30 (-0.30)
Accuray (ARAY) Posts Earnings in Q3, Down on View Cut
Zacks Equity Research - Zacks Investment Research - Wed Apr 27, 10:55AM CDT
Shares of Accuray Inc. (ARAY) fell 3.3% in after-hours trading following the company's third-quarter fiscal 2016 results and trimmed fiscal 2016 guidance.
INGN: 49.46 (-0.77), EXAC: 25.42 (+0.12), ARAY: 5.30 (-0.30), HOLX: 34.14 (-0.81)
Accuray beats 3Q profit forecasts
Automated Insights - Tue Apr 26, 4:05PM CDT
SUNNYVALE, Calif. (AP) _ Accuray Inc. (ARAY) on Tuesday reported fiscal third-quarter net income of $756,000, after reporting a loss in the same period a year earlier.
ARAY: 5.30 (-0.30)
Accuray Submits 510(k) Premarket Notification to FDA for Its Radixact(TM) Treatment Delivery System
PR Newswire - Tue Apr 26, 3:05PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today the submission of its 510(k) premarket notification with the Food and Drug Administration (FDA) for the company's Radixact(TM) Treatment Delivery System. Accuray also submitted 510(k) premarket notification for its treatment planning and data management systems, Precision(TM) Treatment Planning System and iDMS(TM) Data Management System.
ARAY: 5.30 (-0.30)
Accuray Generates $105.3 Million in Third Quarter Revenues
PR Newswire - Tue Apr 26, 3:01PM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today financial results for the third fiscal quarter and nine months ended March 31, 2016.
ARAY: 5.30 (-0.30)
Accuray Hosts Regional AERO Users' Meeting
PR Newswire - Fri Apr 22, 5:00AM CDT
Accuray Incorporated (Nasdaq: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO(TM)) Users' Meeting was held April 10 - 11, 2016 at the Palace Hotel in San Francisco, California. The two day summit, coordinated in partnership with teams from several University of California campuses, brought together radiation oncologists, physicists, therapists and administrators from around the world to discuss best practices and the future of radiation oncology. Founded in 2011, AERO was created for CyberKnife® System and TomoTherapy® System users dedicated to advancing patient care through worldwide clinical and technical collaboration.
ARAY: 5.30 (-0.30)
Natus Medical: A Strong Sell on Weak Q1 & Estimate Revision
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 12:00PM CDT
On Apr 7, Zacks Investment Research downgraded Natus Medical Inc (BABY) to a Zacks Rank #5 (Strong Sell).
BABY: 36.39 (-0.32), GMED: 24.63 (-0.54), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)
T2 Biosystems (TTOO) Rises: Stock Adds 7.6% in Session
Zacks Equity Research - Zacks Investment Research - Thu Apr 07, 7:45AM CDT
T2 Biosystems, Inc. (TTOO) was a big mover last session, as the company saw its shares rise over 7% on the day.
TTOO: 8.90 (-0.26), ARAY: 5.30 (-0.30)
Accuray To Report Results For Third Quarter Fiscal 2016 On April 26, 2016
PR Newswire - Wed Apr 06, 1:14PM CDT
Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2016 on April 26, 2016 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.
ARAY: 5.30 (-0.30)
Mazor Robotics Receives 5 Orders in Q1, Shares Down
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 12:20PM CDT
Shares of Mazor Robotics Ltd. (MZOR) fell 4.1% to close at $11.60 on Apr 5, after the company announced the receipt of five orders for Renaissance system.
GMED: 24.63 (-0.54), MZOR: 15.78 (-0.18), ARAY: 5.30 (-0.30), ANGO: 13.50 (-0.01)
TransEnterix (TRXC) in Focus: Stock Surges 10% in Session
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 7:35AM CDT
TransEnterix, Inc. (TRXC) was a big mover last session, as the company saw its shares surge 10% on the day.
TRXC: 1.45 (+0.01), ARAY: 5.30 (-0.30)
TransEnterix in Focus: Stock Surges 10% in Session
Zacks Equity Research - Zacks Investment Research - Wed Apr 06, 7:35AM CDT
TransEnterix, Inc. (TRXC) was a big mover last session, as the company saw its shares surge 10% on the day.
TRXC: 1.45 (+0.01), ARAY: 5.30 (-0.30)
MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients with the CyberKnife® System
PR Newswire - Thu Mar 31, 5:00AM CDT
Accuray Incorporated (NASDAQ: ARAY) announced today that MedStar Georgetown University Hospital in Washington, D.C. treated its 1,000th prostate cancer patient with the leading-edge CyberKnife® System. The System was designed to deliver stereotactic body radiation therapy (SBRT), a treatment process necessitating an extremely high degree of precision. SBRT is a much shorter course of treatment for prostate cancer patients than conventional radiation and is noninvasive (no surgery involved).
ARAY: 5.30 (-0.30)
Meet the Biotech Company About to Turn the 120-Year-Old Cancer Radiation Industry on Its Head
ACCESSWIRE - Fri Mar 18, 1:49PM CDT
WINDSOR, ON / ACCESSWIRE / March 18, 2016 / The Wealthy Biotech Trader (or "WBT"
, an investment newsletter focused on showing everyday investors new opportunities in rapidly growing, little-known, biotech, pharma and medical device stocks making news and subsequent market moves, would like to highlight a new stock pick, Advanced Medical Isotope (OTC: ADMD), which WBT believes has the ability to cause a massive paradigm shift in the cancer treatment space, and potentially capture a large segment of the burgeoning internal radiation therapy market. We look to follow this company as they expect to make another FDA submission later this year, which should catapult the stock if they receive the anticipated marketing clearance. We also contrast and compare a few other companies in the industry. ATNM: 1.82 (unch), ISR: 0.81 (+0.01), ARAY: 5.30 (-0.30)
Better Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated
Brian Stoffel, The Motley Fool - Motley Fool - Wed Feb 10, 4:01PM CST
Source: Public domain, Pixabay The Nasdaq Composite has had a downright awful seven-week stretch. Since peaking in late December, the collection of companies has seen its value drop by almost 16%. Two of the leading medical tech companies...
ISRG: 641.59 (-6.61), ARAY: 5.30 (-0.30)
Accuray (ARAY) Q2 Loss Wider than Estimate, Shares Fall
Zacks Equity Research - Zacks Investment Research - Mon Feb 01, 9:43AM CST
Shares of Accuray Inc. (ARAY) plunged 8.1% to close at $5.33 on Jan 29 following its dismal second quarter fiscal 2016 earnings results.
GILD: 84.45 (-1.32), EXAC: 25.42 (+0.12), INFI: 4.81 (-0.23), ARAY: 5.30 (-0.30)
